Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lipid Signaling Could Shake Up Biotech In 2012 With Pending Lpath And Peregrine Trial Data
Lipid Signaling Could Shake Up Biotech In 2012 With Pending Lpath And Peregrine Trial Data
Lipid Signaling Could Shake Up Biotech In 2012 With Pending Lpath And Peregrine Trial Data
Submitted by
admin
on November 22, 2011 - 11:57am
Source:
Seeking Alpha
News Tags:
Lpath
lipid signaling
Peregrine Pharmaceuticals
Novartis
Pfizer
Biogen Idec
Headline:
Lipid Signaling Could Shake Up Biotech In 2012 With Pending Lpath And Peregrine Trial Data
Do Not Allow Advertisers to Use My Personal information
